IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

FDA Recall #D-0134-2021 — Class II — November 30, 2020

Recall #D-0134-2021 Date: November 30, 2020 Classification: Class II Status: Ongoing

Product Description

IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Reason for Recall

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Recalling Firm

Advanced Nutriceuticals, LLC — Indianapolis, IN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

3 vials

Distribution

CA, CO, FL, IN, KY, OH, TX

Code Information

Lot # 1029202005,Exp 11/29/2020; Lot #1102202014, Exp 12/08/2020; Lot #1112202002, Exp 12/12/2020

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated